Beta Bionics Files 8-K
Ticker: BBNX · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1674632
| Field | Detail |
|---|---|
| Company | Beta Bionics, Inc. (BBNX) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Beta Bionics filed an 8-K, check for updates.
AI Summary
Beta Bionics, Inc. filed an 8-K on June 23, 2025, reporting events as of June 22, 2025. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates Beta Bionics, Inc. is providing updates to the SEC, which could contain material information for investors regarding the company's status or financial health.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific details of material events, financial performance, or significant changes.
Key Players & Entities
- Beta Bionics, Inc. (company) — Registrant
- June 22, 2025 (date) — Earliest event reported
- June 23, 2025 (date) — Filing date
- 11 Hughes Irvine, California 92618 (address) — Principal executive offices
- (949) 427-7785 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Beta Bionics, Inc.?
The filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
On what date were the earliest events reported in this filing?
The earliest events reported were as of June 22, 2025.
When was this 8-K form filed with the SEC?
The form was filed on June 23, 2025.
What is the principal executive office address for Beta Bionics, Inc.?
The principal executive offices are located at 11 Hughes Irvine, California 92618.
What is the telephone number for Beta Bionics, Inc.?
The registrant's telephone number, including area code, is (949) 427-7785.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Beta Bionics, Inc. (BBNX).